Recombinant paramyosin (rec-Sj-97) tested for immunogenicity and vaccine efficacy against Schistosoma japonicum in mice and water buffaloes

Vaccine

Volumn 20, Issue 5-6, 2001, Pages 870-878

  McManus, Donald P ^a   Wong, Joanna Y M ^a   Zhou, Jinchun ^b   Cai, Chun ^b   Zeng, Qingren ^b   Smyth, Danielle ^a   Li, Yuesheng ^a   Kalinna, Bernd H ^a   Duke, Mary J ^a   Yi, Xinyuan ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Anti fecundity; Asian schistosomiasis; Paramyosin; Schistosoma japonicum; Sj 97; Vaccine; Water buffaloes

Indexed keywords

ADJUVANT; BACTERIAL PROTEIN; IMMUNOGLOBULIN G ANTIBODY; PARAMYOSIN; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; BUFFALO; CATTLE; CHINA; CONTROLLED STUDY; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG TOLERANCE; ENDEMIC DISEASE; IMMUNOGENICITY; INBRED STRAIN; LAKE; LIVER; MATHEMATICAL MODEL; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS; VACCINATION; WORM EGG;

ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; BUFFALOES; CHINA; FEMALE; HUMANS; IMMUNOGLOBULIN G; LIVER; MALE; MICE; MICE, INBRED CBA; PARASITE EGG COUNT; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; TROPOMYOSIN; VACCINES, SYNTHETIC;

EID: 0035852303     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00405-4     Document Type: Article

References (26)

1. Schistosomiasis in the People's Republic of China: Prospects and challenges for the 21st Century
2. Praziquantel: Is there real resistance and are there alternatives
3. Epidemiology of Schistosoma japonicum in China: Morbidity and strategies for control in the Dongting Lake region
4. A baseline study on the importance of bovines for human Schistosoma japonicum infection around Poyang Lake, China
5. Impact of mass chemotherapy with praziquantel on schistosomiasis control in Fanhu village, People's Republic of China
6. A vaccine against Asian schistosomiasis: The story unfolds
7. The development of vaccines for schistosomiasis
8. Gene cloning and complete nucleotide sequence of Philippine Schistosoma japonicum paramyosin
9. Engineering and expression of a full length cDNA encoding Schistosoma japonicum paramyosin: Purification of the recombinant protein and its recognition by infected patient sera
10. Antibodies to Schistosoma japonicum (Asian bloodfluke) paramyosin induced by nucleic acid vaccination
11. B-cell epitopes recognized by Chinese water buffaloes (Bos buffelus) on the 22 kDa tegumental membrane-associated antigen (Sj-22) of the Asiatic bloodfluke. Schistosoma japonicum
12. The vaccine efficacy of native paramyosin (Sj-97) against Chinese Schistosoma japonicum
13. Mathematical modelling of schistosomiasis japonica: Comparison of control strategies in the People's Republic of China
14. Production and properties of a mouse monoclonal IgE antibody to Schistosoma japonicum
15. Demonstration of the target molecule of a protective IgE antibody in secretory glands of Schistosoma japonicum larvae
16. A vaccine trial for controlling reservoir livestock against schistosomiasis japonica
17. Vaccination of domestic pig with recombinant paramyosin against Schistosoma japonicum in CHN
18. Production and testing of Schistosoma japonicum candidate vaccine antigens in the natural ovine host
19. Protective immunity induiuced by the full-length cDNA encoding paramyosin of Chinese Schistosoma japonicum
20. A vaccine against the Asian schistosome, Schistosoma japonicum: An update on paramyosin as a target of protective immunity
21. The search for a vaccine against schistosomiasis - A difficult path but an achievable goal
22. Schistosoma japonicum: Paramyosin immunolocalisation during parasite development
23. Receptor for Fc on the surfaces of schistosomes
24. The role of microscopy in the investigation of paramyosin as a vaccine candidate against Schistosoma japonicum
25. Vaccine candidate MSP-1 from Plasmodium falciparum: A redesigned 4917 bp polynucleotide enables synthesis and isolation of full-length protein from Escherichia coli and mammalian cells
26. Schistosomiasis vaccines: Research to development